{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:22:30Z","timestamp":1777623750284,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-004629"],"award-info":[{"award-number":["INV-004629"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jim.2022.113259","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T13:04:26Z","timestamp":1647608666000},"page":"113259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen"],"prefix":"10.1016","volume":"504","author":[{"given":"Erica D.","family":"Dawson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keely N.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel Y.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahnuma","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutub","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy L.","family":"Rowlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jim.2022.113259_bb0005","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/QCO.0000000000000667","article-title":"Final frontiers of the polio eradication endgame","volume":"33","author":"Bandyopadhyay","year":"2020","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.jim.2022.113259_bb0010","first-page":"545","article-title":"differences in antigenic structure of inactivated polio vaccines made from Sabin live-attenuated and wild-type poliovirus strains: Impact on Vaccine Potency Assays","volume":"221","author":"Crawt","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2022.113259_bb0015","series-title":"package insert","author":"Daptacel","year":"2021"},{"key":"10.1016\/j.jim.2022.113259_bb0020","doi-asserted-by":"crossref","first-page":"I6201","DOI":"10.1136\/bmj.l6201","article-title":"Polio: WHO declares type 3 poliovirus eradicated after 31 year campaign","volume":"367","author":"Dyer","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jim.2022.113259_bb0025","series-title":"package insert","author":"Engerix","year":"2021"},{"key":"10.1016\/j.jim.2022.113259_bb0030","series-title":"package insert","author":"IPOL","year":"2021"},{"key":"10.1016\/j.jim.2022.113259_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2019.113785","article-title":"Universal ELISA for quantification of D-antigen in inactivated poliovirus vaccines","volume":"276","author":"Kouiavskaia","year":"2020","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jim.2022.113259_bb0040","author":"List of Prequalified Vaccines"},{"key":"10.1016\/j.jim.2022.113259_bb0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jphp.12352","article-title":"Particulate inorganic adjuvants: recent developments and future outlooks","volume":"67","author":"Maughan","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jim.2022.113259_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113056","article-title":"Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant","volume":"494","author":"McAdams","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2022.113259_bb0055","first-page":"504","article-title":"Sabin strain inactivated polio vaccine for the polio endgame","volume":"221","author":"Modlin","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2022.113259_bb0060","series-title":"Relationship Between the Degree of Antigen Adsorption in the Vaccine or in Interstitial Fluid and the Ensuing Immune Response","author":"Mudholkar","year":"2001"},{"issue":"6","key":"10.1016\/j.jim.2022.113259_bb0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biologicals.2016.08.005","article-title":"Development of inactivated poliovirus vaccine from Sabin strains: A progress report","volume":"44","author":"Okayasu","year":"2016","journal-title":"Biologicals"},{"issue":"9","key":"10.1016\/j.jim.2022.113259_bb0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJMp1808903","article-title":"Ending use of oral poliovirus vaccine \u2013 A difficult move in the polio endgame","volume":"379","author":"Pallansch","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2022.113259_bb0075","series-title":"Package Insert","author":"Pediarix","year":"2019"},{"key":"10.1016\/j.jim.2022.113259_bb0080","series-title":"package insert","author":"Pentacel","year":"2021"},{"key":"10.1016\/j.jim.2022.113259_bb0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/jcis.1998.5648","article-title":"Effect of pH on the elution of model antigens from aluminum-containing adjuvants","volume":"205","author":"Rinella","year":"1998","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jim.2022.113259_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/jcis.1997.5230","article-title":"Elutability of proteins from aluminum-containing vaccine adjuvants by treatment with surfactants","volume":"197","author":"Rinella","year":"1998","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jim.2022.113259_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/mps3030062","article-title":"Characterization of competitive ELISA and Formulated Alhydrogel competitive ELISA (FAcE) for direct quantification of active ingredients in GMMA-based vaccines","volume":"3","author":"Rossi","year":"2020","journal-title":"Methods Protoc"},{"key":"10.1016\/j.jim.2022.113259_bb0100","first-page":"156","article-title":"Solubilization of aluminum-containing adjuvants by constituents of interstitial fluid","volume":"45","author":"Seeber","year":"1991","journal-title":"J. Parenter. Sci. Technol."},{"key":"10.1016\/j.jim.2022.113259_bb0105","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/j.vaccine.2015.03.076","article-title":"sIPV process development for costs reduction","volume":"33","author":"Thomassen","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jim.2022.113259_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083374","article-title":"Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals","volume":"8","author":"Thomassen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2022.113259_bb0115","first-page":"S20","article-title":"A brief history of vaccines against polio","volume":"53","author":"Vashishtha","year":"2016","journal-title":"Indian Pediatr."},{"issue":"2","key":"10.1016\/j.jim.2022.113259_bb0120","first-page":"id1009","article-title":"The final stage of developing genetically modified inactivated Sabin vaccine for the eradication of poliovirus, Austin","volume":"1","author":"Yee","year":"2015","journal-title":"J. Microbiol."},{"key":"10.1016\/j.jim.2022.113259_bb0125","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.vaccine.2009.07.067","article-title":"Use of O-phthalaldehyde assay to determine protein contents of alhydrogel-based vaccines","volume":"27","author":"Zhu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2022.113259_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vaccine.2011.11.025","article-title":"Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer","volume":"30","author":"Zhu","year":"2012","journal-title":"Vaccine"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175922000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175922000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:59:37Z","timestamp":1777417177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175922000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":26,"alternative-id":["S0022175922000461"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2022.113259","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.30.458257","asserted-by":"object"}]},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2022.113259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113259"}}